| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/04/2007 | CA2232450C Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 09/04/2007 | CA2181033C Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections |
| 09/04/2007 | CA2134479C Laser treatment |
| 08/30/2007 | WO2007098270A2 Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same |
| 08/30/2007 | WO2007098033A2 Feedback prodrug |
| 08/30/2007 | WO2007097624A1 Pharmaceutical compositions for the treatment of influenza infections |
| 08/30/2007 | WO2007097461A1 Antibody for treatment of hepatitis c |
| 08/30/2007 | WO2007097386A1 Stabilized pharmaceutical composition |
| 08/30/2007 | WO2007097370A1 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND |
| 08/30/2007 | WO2007097325A1 Pharmaceutical composition comprising oseltamivir phosphate |
| 08/30/2007 | WO2007096160A1 Aerosol and use thereof |
| 08/30/2007 | WO2007095830A1 Powder perfusion agent used in the treatment of bovine mastitis and its preparing process |
| 08/30/2007 | WO2007095784A1 The triazolyl-containing oxazolidinone derivatives, the preparation method and the uses thereof |
| 08/30/2007 | WO2007079260A9 Methods for improving the pharmacokinetics of hiv integrase inhibitors |
| 08/30/2007 | WO2007077454A3 A therapeutic composition comprising an inhibitor of an hsp 90 protein |
| 08/30/2007 | WO2007077203A3 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases |
| 08/30/2007 | WO2007070556A3 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 08/30/2007 | WO2007060618A3 Macrolides derivatives as antibacterial agents |
| 08/30/2007 | WO2007054279A3 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 08/30/2007 | WO2007050978A3 Methods for the elimination of pathogens and other particulate agents |
| 08/30/2007 | WO2007036802A3 Sublingual dosage form comrising vitamin d analogue, in particular calcitriol |
| 08/30/2007 | WO2007032794A3 Inhibition of viral gene expression using small interfering rna |
| 08/30/2007 | WO2006134497A3 Uses of recombinant super-compound interferons |
| 08/30/2007 | US20070203339 Process for Preparation of Cyclic Prodrugs of PMEA and PMPA |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/30/2007 | US20070203187 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 08/30/2007 | US20070203185 Therapeutical Composition Containing Dentritic Cells And Use Thereof |
| 08/30/2007 | US20070202574 Novel Saccharothrix Strain an Antibiotics Derived Therefrom, i.e. Mutactimycins and Aldgamycins |
| 08/30/2007 | US20070202501 Proteins Expressed In Ink Cells |
| 08/30/2007 | US20070202201 Pharmaceutics of treaditiional chinese medicine of treating aids and preparation method thereof |
| 08/30/2007 | US20070202198 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors biofilters and bioreactors |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | US20070202123 Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids |
| 08/30/2007 | US20070202116 Staphylococcal infections using glycopeptide antibiotic eg vancomycin |
| 08/30/2007 | US20070202115 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 08/30/2007 | US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 08/30/2007 | US20070202099 Antibody Drug |
| 08/30/2007 | US20070202078 Method Of Treating Viral Infections |
| 08/30/2007 | DE60122300T2 Hepatitis b kernprotein fusionsproteine Hepatitis B core protein fusion proteins |
| 08/30/2007 | DE102006008321A1 Mittel zur Behandlung von Infektionen mit Influenzaviren Agents for the treatment of infections with influenza viruses |
| 08/30/2007 | DE102006007830A1 Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure A storage-stable oral dosage form of amoxicillin and clavulanic acid |
| 08/30/2007 | DE102004055891B4 Gemische von Schlangengiften zur Krankheitsbekämpfung Mixtures of snake venoms disease control |
| 08/30/2007 | CA2643688A1 Co-crystals and pharmaceutical compositions comprising the same |
| 08/30/2007 | CA2643028A1 Substituted taraxastanes useful for treating viral infections |
| 08/30/2007 | CA2642952A1 Pharmaceutical composition comprising oseltamivir phosphate |
| 08/30/2007 | CA2640331A1 Stabilized pharmaceutical composition |
| 08/30/2007 | CA2618741A1 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 08/29/2007 | EP1826217A1 Method for identification of antigenic peptides |
| 08/29/2007 | EP1826198A1 Method for the synthesis of the sodium salt of retinoyl-cysteic acid and retinoyl-cysteine sulfinic acid |
| 08/29/2007 | EP1825863A1 Recombinant porcine adenovirus vector |
| 08/29/2007 | EP1824978A1 Hcv f protein and uses thereof |
| 08/29/2007 | EP1824976A1 Antimicrobial peptides |
| 08/29/2007 | EP1824957A2 Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1 |
| 08/29/2007 | EP1824883A2 Saquinavir derivatives useful in immunoassay |
| 08/29/2007 | EP1824873A1 Use of derivatives of dipeptides for the manufacture of a medicament for the treatment of microbial infections |
| 08/29/2007 | EP1824871A1 Macrolone compounds |
| 08/29/2007 | EP1824870A1 Macrolones - amino substituted quinolones |
| 08/29/2007 | EP1824869A1 Macrolone compounds |
| 08/29/2007 | EP1824863A1 Silicon compounds and their use |
| 08/29/2007 | EP1824862A1 Silicon compounds and their use |
| 08/29/2007 | EP1824514A2 Toll like receptor 3 antagonists, methods and uses |
| 08/29/2007 | EP1824507A1 Treatment of hepatitis c in the asian population with interferon-beta |
| 08/29/2007 | EP1824497A1 Macrolone compounds |
| 08/29/2007 | EP1824456A2 Micronised azodicarbonamide, the preparation and use thereof |
| 08/29/2007 | EP1651244B1 Use of extracts from roots of Pelargonium sidoides and/or Pelargonium Reniforme |
| 08/29/2007 | EP1648476B1 Mouth and/or throat wash |
| 08/29/2007 | EP1644385B1 Silicon compounds and their use |
| 08/29/2007 | EP1517899B1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 08/29/2007 | EP1414961B1 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 08/29/2007 | EP1165781B1 Protease resistant flint analogs |
| 08/29/2007 | EP1140997B1 Chlamydia trachomatis antigens |
| 08/29/2007 | EP1047301B1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/29/2007 | EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/29/2007 | EP0998585B1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 08/29/2007 | CN200939251Y Se-garlic capsules |
| 08/29/2007 | CN101027312A 抗病毒化合物 Antiviral compounds |
| 08/29/2007 | CN101027299A Carbo- and hetero-cyclic antibiotics and use thereof |
| 08/29/2007 | CN101027296A Oxazolidinone compounds and compositions and methods related thereto |
| 08/29/2007 | CN101027288A HIV inhibiting 5-substituted pyrimidines |
| 08/29/2007 | CN101027084A Mutated HIV NEF for modulating immunity |
| 08/29/2007 | CN101027051A Methods for treating hepatitis C |
| 08/29/2007 | CN101024842A Expression vectors encoding epitopes of target-associated antigens and its design method |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024668A Two-chain small-molecular interference ribonucleic acid and its compination for treating preventing and treating AIDS |
| 08/29/2007 | CN101024665A Decarboxylated FR-008 derivative polyketone antibiotic and use thereof |
| 08/29/2007 | CN101024640A Lignin in dandelion, its bacteria-resisting activity and use for medicine |
| 08/29/2007 | CN101024637A Sesquiterplactone in dandelion and its use of resisting Gram's positive bacteria |
| 08/29/2007 | CN101024636A Eremophilane containing chlorine atom in Heizituowu and its anti-biotic and cell-toxin activity |
| 08/29/2007 | CN101024088A B-type hepatitis virus micro ribonucleic-acid interference moleculars and its designing method |
| 08/29/2007 | CN101024080A Dolphin streptococcal white-oil adjuvant inactivated vaccine and preparing method |
| 08/29/2007 | CN101024079A Pneumo-streptococcal-polysaccharide adventitia jointed vaccine and preparing method |
| 08/29/2007 | CN101024078A Use of short-small-rod like bacillus for preparing pig's infections pleuropneumonia biological preparation |
| 08/29/2007 | CN101024077A Tubercle-bacillus recombined vaccine |
| 08/29/2007 | CN101024076A Novel use of coccidium |
| 08/29/2007 | CN101024059A Oral Chinese medicine preparation for resisting virus and treating respiratory tract infection |
| 08/29/2007 | CN101024056A Method for preparing toxin-reducing bacteria vaccine for domestic animals, fowls |
| 08/29/2007 | CN101024051A Medicine for treating athlete's foot |